| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6182599 | Gynecologic Oncology | 2016 | 10 Pages | 
Abstract
												PD-L1 is primarily expressed by macrophages in ovarian cancer and is strongly associated with both cytolytic and regulatory TIL subsets, resulting in a net positive association with survival. Tumors containing PD-L1+ macrophages appear caught in an immunological stalemate that may require multi-pronged immunotherapy to alleviate.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												John R. Webb, Katy Milne, David R. Kroeger, Brad H. Nelson, 
											